BNTC Benitec Biopharma Inc.

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 2d 2h ago
Institutional cluster: 3 buyers, 1 sellers (bullish)

Executive Summary

Three mega-passive institutional investors (BlackRock, State Street, Fidelity) collectively added $6.1M in BNTC during Q3 2025, while Morgan Stanley trimmed $175K. The buying is dominated by index-fund rebalancing rather than active conviction, and historical calibration shows this filing type has a negative average alpha at T+20 (-2.04%). The cluster signal is weak given the passive nature of the buyers and the small absolute dollar amounts relative to BNTC's $357M market cap.

Key Financial Metrics

Direction
accumulating
Buy Value
$16.3M
Sell Value
$402.0K
Net Flow
$5.9M

Institutional Positions

Net institutional flow: $5.9M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
BlackRock ADD +31.6% $13.3M $4.9M
State Street ADD +35.6% $3.1M $1.2M
Fidelity DOUBLED +567.2% $17.0K $15.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Morgan Stanley TRIM -53% $402.0K -$175.4K

Actionable Insight

The cluster is entirely passive/index-fund buying, likely reflecting BNTC's inclusion in or increased weighting within Russell or other indices. No active manager conviction signal exists. Monitor for any active fund 13F filings in subsequent quarters for a genuine institutional thesis read.

Key Facts

  • 3 institutional buyers added $6.1M in aggregate BNTC holdings during Q3 2025
  • BlackRock increased its position by 31.6% to $13.3M, the largest buyer
  • State Street added 35.6% to $3.1M; Fidelity doubled a tiny position to $17K
  • Morgan Stanley trimmed 53% of its BNTC stake, selling $175K
  • All four funds are mega-passive/index-trackers — no active managers or hedge funds in the cluster
  • Historical calibration shows this filing segment has a net negative average alpha of -2.04% at T+20

Financial Impact

3 institutional buyers accumulated $6.1M in new BNTC positions while 1 seller reduced holdings by $175K, for net buying of approximately $5.9M

institutional ownershipfloat

Risk Factors

  • Passive buying provides no fundamental thesis signal — may reverse on next index rebalance
  • Historical calibration shows negative average alpha at T+20 for this filing type
  • Small absolute dollar amounts ($6.1M vs $357M market cap) limit potential impact

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-BNTC-2025-Q3
5 reports for BNTC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BNTC — sortable, filterable
Type Now
Jun 11, 2026
1d ago
Institutional Cluster
NEUTRAL ★ 3/10
$10.90 awaiting T+5awaiting T+5
Jun 11, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 3/10
$10.40 awaiting T+5awaiting T+5
May 14, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$11.85 $11.36▼ −4.13%▼ −3.42%
May 14, 2026
4w ago
Press Release
BULLISH ★ 6/10
$11.85 $11.36▼ −4.13%▼ −3.42%
Mar 10, 2026
13w ago
Press Release
BULLISH ★ 8/10
$12.27 $11.75▼ −4.24%▼ −3.33%
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (47h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access